Systematic review of guidelines on peripheral artery disease screening

American Journal of Medicine

Volumn 125, Issue 2, 2012, Pages

  Ferket, Bart S ^a   Spronk, Sandra ^a   Colkesen, Ersen B ^b   Hunink, M G Myriam ^a,c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Ankle brachial index; Guidelines; Peripheral artery disease; Screening; Systematic review

Indexed keywords

ANKLE BRACHIAL INDEX; ARTICLE; CARDIOVASCULAR RISK; HUMAN; MEDICAL SOCIETY; META ANALYSIS (TOPIC); PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SYSTEMATIC REVIEW (TOPIC);

EID: 84856106620     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2011.06.027     Document Type: Review

References (42)

1. E. Selvin, T.P. Erlinger Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000 Circulation 110 6 2004 738 743 (Pubitemid 39056275)
2. W.R. Hiatt Medical treatment of peripheral arterial disease and claudication N Engl J Med 344 21 2001 1608 1621 (Pubitemid 32479915)
3. C.L. Heald, F.G. Fowkes, G.D. Murray, J.F. Price Risk of mortality and cardiovascular disease associated with the ankle-brachial index: systematic review Atherosclerosis 189 1 2006 61 69 (Pubitemid 44441297)
4. F.G. Fowkes, G.D. Murray, I. Butcher Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis JAMA 300 2 2008 197 208 (Pubitemid 351969304)
5. G.F. Sawaya, J. Guirguis-Blake, M. LeFevre Update on the methods of the U.S. Preventive Services Task Force: estimating certainty and magnitude of net benefit Ann Intern Med 147 12 2007 871 875 (Pubitemid 351664424)
6. T.B. Mendelson, M. Meltzer, E.G. Campbell Conflicts of interest in cardiovascular clinical practice guidelines Arch Intern Med 171 6 2011 577 584
7. B. Lo Serving two mastersconflicts of interest in academic medicine N Engl J Med 362 8 2010 669 671
8. B.S. Ferket, E.B. Colkesen, J.J. Visser Systematic review of guidelines on cardiovascular risk assessment: which recommendations should clinicians follow for a cardiovascular health check? Arch Intern Med 170 1 2010 27 40
9. I.D. Graham, M.B. Harrison Evaluation and adaptation of clinical practice guidelines Evid Based Nurs 8 3 2005 68 72
10. M.J. Field, K.N. Lohr Clinical Practice Guidelines: Directions for a New Program 1990 National Academy Press Washington, DC
11. AGREE Collaboration Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project Qual Saf Health Care 12 1 2003 18 23
12. Appraisal of Guidelines Research and Evaluations (AGREE) AGREE Web site http://www.agreecollaboration.org Accessed January 20, 2011
13. U.S. Preventive Services Task Force Using nontraditional risk factors in coronary heart disease risk assessment: U.S. Preventive Services Task Force recommendation statement Ann Intern Med 151 7 2009 474 482
14. U.S. Preventive Services Task Force Screening for Peripheral Arterial Disease: Recommendation Statement 2005 U.S. Preventive Services Task Force Rockville, MD
15. P. Greenland, J.S. Alpert, G.A. Beller 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance J Am Coll Cardiol 56 25 2010 e50 e103
16. A.T. Hirsch, Z.J. Haskal, N.R. Hertzer ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation Circulation 113 11 2006 e463 e654
17. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults III Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 25 2002 3143 3421
18. S.M. Grundy, J.I. Cleeman, C.N. Merz Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 110 2 2004 227 239 (Pubitemid 38924592)
19. J. Genest, R. McPherson, J. Frohlich 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations Can J Cardiol 25 10 2009 567 579
20. L. Norgren, W.R. Hiatt, J.A. Dormandy Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) Eur J Vasc Endovasc Surg 33 Suppl 1 2007 S1 S75
21. B.L. Abramson, V. Huckell, S. Anand Canadian Cardiovascular Society Consensus Conference: peripheral arterial disease - executive summary Can J Cardiol 21 12 2005 997 1006 (Pubitemid 41723264)
22. F.G. Fowkes, E. Housley, R.A. Riemersma Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study Am J Epidemiol 135 4 1992 331 340
23. T. Jonason, R. Bergstrom Cessation of smoking in patients with intermittent claudication Effects on the risk of peripheral vascular complications, myocardial infarction and mortality Acta Med Scand 221 3 1987 253 260 (Pubitemid 17069424)
24. K.W. Faulkner, A.K. House, W.M. Castleden The effect of cessation of smoking on the accumulative survival rates of patients with symptomatic peripheral vascular disease Med J Aust 1 5 1983 217 219 (Pubitemid 13093285)
25. I.O. Ingolfsson, G. Sigurdsson, H. Sigvaldason A marked decline in the prevalence and incidence of intermittent claudication in Icelandic men 1968-1986: a strong relationship to smoking and serum cholesterolthe Reykjavik Study J Clin Epidemiol 47 11 1994 1237 1243 (Pubitemid 24361531)
26. N.R. Anthonisen, M.A. Skeans, R.A. Wise The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial Ann Intern Med 142 4 2005 233 239 (Pubitemid 40216240)
27. S. Tonstad, C. Farsang, G. Klaene Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study Eur Heart J 24 10 2003 946 955 (Pubitemid 36559988)
28. D.E. Jorenby, S.J. Leischow, M.A. Nides A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation N Engl J Med 340 9 1999 685 691 (Pubitemid 29110752)
29. A.W. Gardner, E.T. Poehlman Exercise rehabilitation programs for the treatment of claudication pain A meta-analysis JAMA 274 12 1995 975 980
30. G.C. Leng, B. Fowler, E. Ernst Exercise for intermittent claudication Cochrane Database Syst Rev 2 2 2000 CD000990
31. B. Fowler, K. Jamrozik, P. Norman Improving maximum walking distance in early peripheral arterial disease: randomised controlled trial Aust J Physiother 48 4 2002 269 275 (Pubitemid 36007858)
32. M.M. McDermott, J.M. Guralnik, P. Greenland Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease Circulation 107 5 2003 757 761 (Pubitemid 36222606)
33. S. Yusuf, P. Sleight, J. Pogue Effects of an angiotensin-converting- enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients The Heart Outcomes Prevention Evaluation Study Investigators N Engl J Med 342 3 2000 145 153
34. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 9326 2002 7 22
35. C. Baigent, A. Keech, P.M. Kearney Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 9493 2005 1267 1278
36. Antithrombotic Trialists' Collaboration Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ 324 7329 2002 71 86
37. J.A. Beckman, M.R. Jaff, M.A. Creager The United States preventive services task force recommendation statement on screening for peripheral arterial disease: more harm than benefit? Circulation 114 8 2006 861 866 (Pubitemid 44274923)
38. P.M. Kearney, L. Blackwell, R. Collins Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis Lancet 371 9607 2008 117 125
39. J.S. Berger, M.C. Roncaglioni, F. Avanzini Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials JAMA 295 3 2006 306 313
40. Heart Protection Study Collaborative Group Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions J Vasc Surg 45 4 2007 645 654 discussion 53-4
41. F.G. Fowkes, J.F. Price, M.C. Stewart Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial JAMA 303 9 2010 841 848
42. S.E. Nissen Can we trust cardiovascular practice guidelines? comment on "conflicts of interest in cardiovascular clinical practice guidelines" Arch Intern Med 171 6 2011 584 585